Background
Methods
Inclusion/exclusion criteria
Information sources
Initial search: Assessment retrieval | Database and Search Terms | Limitations |
---|---|---|
Subject Headings | Embase: (Questionnaire/) AND (Physical capacity/ OR “physical constitution and health”/ OR “movement (physiology)”/ OR “physical activity, capacity and performance”/ OR Exercise/ OR Performance/ OR Motor performance/) AND (Validation study/ OR validity/ OR Psychometry/ OR Reliability/ OR Measurement accuracy/ OR measurement error/ OR measurement precision/ OR measurement repeatability/) | Humans; English; Adult: 18 to 64 years OR Aged: 65+ years |
PubMed: (“Physical Conditioning, Human”[Mesh] OR “Physical Fitness”[Mesh] OR “Physical Therapy Modalities”[Mesh] OR “Physical Endurance”[Mesh] OR “Physical Exertion”[Mesh] OR “Exercise”[Mesh] OR “Motor Activity”[Mesh] OR “Exercise”[Mesh] OR “Exercise Movement Techniques”[Mesh] OR “Exercise Therapy”[Mesh] OR “Psychomotor Performance”[Mesh] OR “Motor Skills”[Mesh] OR “Motor Activity”[Mesh]) AND (“Surveys and Questionnaires”[Mesh]) AND (“Psychometrics”[Mesh] OR “Reproducibility of Results”[Mesh] OR “Validation Studies as Topic”[Mesh] OR “Bias (Epidemiology)”[Mesh] OR “Observer Variation”[Mesh]) | Humans; English; Adult: 19+ years | |
Free Text Words | Embase: (questionnaire*) AND (physic* OR movement* OR capacit* OR exercise* OR train* OR performance* OR motor) AND (psychometric* OR reliability OR validit* OR reproducibility OR bias) | Publication date from 2017 – current |
PubMed: As per Embase Free Text | Publication date from 2016/12/09 to 2017/06/09 |
Selection process
Assess study methodological quality using COSMIN ratings
Psychometric property | Domain: Definition |
---|---|
Validity: The degree to which an HR-PRO instrument measures the construct(s) it purports to measure | |
Content validity | The degree to which the content of an HR-PRO instrument is an adequate reflection of the construct to be measured |
Face validitya | The degree to which an HR-PRO instrument indeed looks as though they are an adequate reflection of the construct to be measured |
Construct validity | The degree to which the scores of an HR-PRO instrument are consistent with hypotheses based on the assumption that a HR-PRO instrument validly measures the construct to be measured |
Structural validityb | The degree to which the scores of an HR-PRO instrument are an adequate reflection of the dimensionality of the construct to be measured |
Hypothesis testingb | Item construct validity |
Criterion validity | The degree to which the scores of an instrument satisfactorily reflect a “gold standard” |
Responsiveness | Responsiveness: the capability of an HR-PRO instrument to detect change in the construct to be measured over time |
Interpretabilityc | Interpretability: the extent to which qualitative meaning is reflective of an instrument’s quantitative scores or score change |
Reliability: The degree to which the measurement is free from measurement error | |
Internal consistency | The degree of the interrelatedness among the items |
Reliability | The proportion of total variance in the measurements due to “true” differences amongst patients |
Measurement error | The systematic and random error of a patient’s score that is not attributed to true changes in the construct to be measured |
Quality of the psychometric properties
Psychometric property | Score a | Quality Criteria b |
---|---|---|
Content validity | + | A clear description is provided of the measurement aim, the target population, the concepts that are being measured, and the item selection AND target population and (investigators OR experts) were involved in item selection |
? | A clear description of above-mentioned aspects is lacking OR only target population involved OR doubtful design or method | |
– | No target population involvement | |
± | Conflicting results | |
NR | No information found on target population involvement | |
NE | Not evaluated | |
Structural validityc | + | Factors should explain at least 50% of the variance |
? | Explained variance not mentioned | |
– | Factors explain < 50% of the variance | |
± | Conflicting results | |
NR | No information found on structural validity | |
NE | Not evaluated | |
Hypothesis testingc | + | Specific hypotheses were formulated AND at least 75% of the results are in accordance with these hypotheses; Convergent validity: correlation between similar assessments is at a statistically significant level (p < 0.05) and strength of relationship is ≥0.5 which is consistent with the hypothesis; Discriminant validity: uses appropriate statistical analysis (e.g., t-test p < 0.05 or Cohen’s d effect size ≥0.5) |
? | Doubtful design or method (e.g., no hypotheses) | |
– | Less than 75% of hypotheses were confirmed, despite adequate design and methods; Convergent validity: correlation between similar assessments is not at a statistically significant level (p ≥ 0.05) and strength of relationship is < 0.5 which is inconsistent with hypothesis | |
± | Conflicting results between studies within the same manual | |
NR | No information found on hypotheses testing | |
NE | Not evaluated | |
Internal consistency | + | Factor analyses performed on adequate sample size (7 * # items and 100) AND Cronbach’s alpha(s) calculated per dimension AND Cronbach’s alpha(s) between 0.70 and 0.95 |
? | No factor analysis OR doubtful design or method | |
– | Cronbach’s alpha(s) < 0.70 or > 0.95, despite adequate design and method | |
± | Conflicting results | |
NR | No information found on internal consistency | |
NE | Not evaluated | |
Reliability | + | ICC or weighted Kappa 0.70 |
? | Doubtful design or method (e.g., time interval not mentioned) | |
– | ICC or weighted Kappa < 0.70, despite adequate design and method | |
± | Conflicting results | |
NR | No information found on reliability | |
NE | Not evaluated | |
Measurement errord | + | MIC < SDC OR MIC outside the LOA OR convincing arguments that agreement is acceptable |
? | Doubtful design or method OR (MIC not defined AND no convincing arguments that agreement is acceptable) | |
– | MIC SDC OR MIC equals or inside LOA, despite adequate design and method | |
± | Conflicting results | |
NR | No information found on measurement error | |
NE | Not evaluated |
Data items and synthesis of results
Instrument | Purpose of instrument | Published year | Type of administration/Recall method | Number of subscales/forms | Total number of items | Response options |
---|---|---|---|---|---|---|
Usual-week Physical Activity Questionnaires | ||||||
CaMos Usual-week | To assess physical activity among those with susceptibility to osteoporosis | 2004 | Usual 7-days over 12 months | 4 | 10 | Type of occupation: • Full-time/Part-time/Unemployed/Disabled/Retired • Mostly sitting/Mostly standing or walking/Usually lift light loads/Usually lift heavy loads Strenuousness of activity: • Hours/week Sitting activities: • Hours/week Sleep: • Hours/day |
IPEQ-WA Usual-week | To assess incidental physical activity among older adults | 2010 | Usual 7-days over 3 months | 10 | 16 | Type of activity: • Minutes/week Walking for exercise: • Times/week • Minutes/bout Incidental walking: • Times/week • Minutes/bout House maintenance/gardening: • Minutes/day Time on feet indoors: • Minutes/day |
MAQ Usual-week | To assess physical activity among the general population | 1990 | Usual 7-days over 12 months | 6 | 9 | Type of activity: • Times/month • Minutes/bout Television viewing: • Hours/day Confined to bed or chair from injury/illness: • Weeks/year Difficulties with activities: • Yes/no Types of sports: • Total years Walk/cycle to work: • Min/day |
NHS II Usual 7-days | To assess the health conditions of nurses working at hospitals | 1989 | Usual 7-days over 12 months | 3 | 16 | Daily flights of stairs: • ≤ 2; 3–4; 5–9; 10–14; ≥ 15 Physical activity per week: • 0–11+ hours Sedentary time per week: • 0–90+ hours |
Phone-FITT Usual-week | To assess physical activity among older adults via phone | 2008 | Usual 7-days over 1 month | 9 | 16 | Type of household activity: • Hours/week Type of recreational activity: • Hours/week Type of seasonal recreational activity: • Hours/week Other physical activity: • Hours/week |
YPAS Usual 7-days | To assess physical activity among Volder adults | 1993 | Usual 7-days over 1 month | 6 | 39 | Type of activity: • Hours/week Vigorousness of activity: • Frequency /week or /month Leisurely walk: • Frequency /week or /month; Duration in minutes General movement: • Hours/day Standing and sitting: • Hours/day Seasonal changes: • Compare current season |
Past-week Physical Activity Questionnaires | ||||||
AAS Past 7-days | Population surveillance of physical activity in Australian adults | 2003 | Past 7-days | 4 | 8 | Walking activities: • Frequency/week; Hours/week; minutes/week Vigorous yard work: • Frequency/week; Hours/week; minutes/week Vigorous activities other than yard work: • Frequency/week; Hours/week; minutes/week Moderate activities: • Frequency/week; Hours/week; minutes/week |
AAS (modified) | Population surveillance of physical activity in Australian adults | 2013 | Past 7-days | 4 | 8 | Walking activities: • Frequency/week; Hours/week; minutes/week Vigorous yard work: • Frequency/week; Hours/week; minutes/week Vigorous activities other than yard work: • Frequency/week; Hours/week; minutes/week Moderate activities: • Frequency/week; Hours/week; minutes/week |
CAQ-PAI Past 7-days | To measure overall kilocalories expended in leisure-time physical activity | 1978 | Past 7-days | 3 | 4 | Walking: • Blocks/day Stairs: • Flights/day Recreational activities: • Frequency/week; Hours/week; minutes/session |
Checklist Questionnaire Past 7-days | Assess the frequency and duration of physical activities performed in the previous 7 days | 2012 | Past 7-days | 10 | 64 | Household activities: • Frequency/week; Hours/week; minutes/week Yard activities: • Frequency/week; Hours/week; minutes/week Family activities: • Frequency/week; Hours/week; minutes/week Community/volunteer/church: • Frequency/week; Hours/week; minutes/week Transportation: • Frequency/week; Hours/week; minutes/week Miscellaneous: • Frequency/week; Hours/week; minutes/week Other time: Exercise, sports and dancing: • Frequency/week; Hours/week; minutes/week Employment: • Frequency/week; Hours/week; minutes/week Miscellaneous: • Frequency/week; Hours/week; minutes/week |
Global Questionnaire | To assess physical activity among older adults | 2001 | Past 7-days | 5 | 35 | Type of activity: • Hours/week Vigorousness of activity: • Frequency/week or /month Leisurely walk: • Frequency/week or /month; Duration in minutes General movement: • Hours/day |
IPAQ-LF Past 7-days | As for IPAQ-LF (Telephone) | 2002 | Past 7-days | As for IPAQ-LF (Telephone) | As for IPAQ-LF (Telephone) | Vigorous activities • Days/week; Hours/week; minutes/day Moderate activities • Days/week; Hours/week; minutes/day Light activities • Days/week; Hours/week; minutes/day Sitting time • Days/week; Hours/week; minutes/day |
IPAQ-SF Past 7-days | As for IPAQ-LF (Telephone version) | 2002 | Past 7-days | 4 | 7 | Vigorous activities • Days/week; Hours/week; minutes/day Moderate activities • Days/week; Hours/week; minutes/day Light activities • Days/week; Hours/week; minutes/day Sitting time • Days/week; Hours/week; minutes/day |
NZPAQ-LF | Retrospective diary that assesses all dimensions of physical activity type and level in New Zealand | 2008 | Past 7-days | 5 | 11 | Sport/recreation: • Days/week; Hours/week; minutes/day Transport: • Days/week; Hours/week; minutes/day Occupation: • Days/week; Hours/week; minutes/day Cultural/incidental activities: • Days/week; Hours/week; minutes/day Inactivity: • Days/week; Hours/week; minutes/day |
NZPAQ-SF | Modified version of IPAQ-SF to assess physical activity level whilst reflecting the culture in New Zealand | 2008 | Past 7-days | 4 | 7 | Walking activities: • Days/week; Hours/week; minutes/day Moderate physical activity: • Days/week; Hours/week; minutes/day Vigorous physical activity • Days/week; Hours/week; minutes/day: Frequency of activity: • Days/week; Hours/week; minutes/day |
PAAQ | To assess physical activity level in line with the Canadian Physical Activity Guidelines | 2015 | Past 7-days | 4 | 12 | Walking or cycling to destination • Yes/No • Days/week; Hours/week; minutes/day Recreational activities, organised activities lasting minimum of 10 min that caused sweat or hard breathing: • Yes/No • Days/week; Hours/week; minutes/day Activities at work, home or volunteering that caused sweat or hard breathing: • Yes/No • Days/week; Hours/week; minutes/day Vigorous exercises that caused breathlessness: • Yes/No • Days/week; Hours/week; minutes/day |
PASE Past 7-days | To assess leisure, occupational and household physical activities amongst the elderly | 1991 | Past 7-days | 3 | 27 | Recreational activities: • Frequency/week; < 1 h, 1–2 h, 2–4 h or > 4 h Household activities: • Yes or no; Type of activities Occupational activities: • Hours/week; Type of activities |
PWMAQ | To assess leisure physical activities during the past week | 2009 | Past 7-days | 6 | 9 | Type of activity: • Times/week • Minutes/bout Television viewing: • Hours/day Confined to bed or chair from injury/illness: • Minutes/week Difficulties with activities: • Yes/no Types of sports: • Total years Walk/cycle to work: • Min/day |
PAR Past 7-days | To assess sleep and physical activity patterns | 1985 | Past 7-days | 6 | 15 | Occupational activities: • Yes or No; Frequency/week; Hours/week; Days/week Moderate, Hard and Very Hard in the Morning: • Minutes Moderate, Hard and Very Hard in the Afternoon: • Minutes Moderate, Hard and Very Hard in the Evening: Strength: • Minutes Flexibility: • Minutes |
VAPAQ
Past 7-days
| To measures physical activities amongst veterans | 2003 | Past 7-days | 3 | 6 | Walking activities: • Blocks/day Sports/recreational activities: • Frequency/week; Hours/week; minutes/session Occupational activities: • Frequency/week; Hours/week; minutes/session |
Results
Systematic literature search
Included physical activity questionnaires
Instrument | Reference | Purpose of study | Study population | Health condition | Age range (R; mean ± standard deviation) |
---|---|---|---|---|---|
Usual-week Physical Activity Questionnaires | |||||
CaMos
Usual-week
| Nadalin, Bentvelsen [45] | To assess test-retest reliability of a portion of the CaMos questionnaire using a combination of administration modes | Reliability (N = 367) | Physical: healthy with possible osteoporosis Cognitive: Not screened | Total sample: R = 45–80 (NR)y |
IPEQ-WA
Usual-week
| Merom, Delbaere [46] | Assessed construct validity and responsiveness of IPEQ | Male (I) & Female (II): Validity (N = 40 & 86) | Physical: No chronic disease conditions Cognitive: Healthy based on cognitive test | Total sample: R = NR; (I) NR; (II) NR |
MAQ
Usual-week
| Pettee Gabriel, McClain [47] | Test-retest reliability and convergent validity of five PAQs commonly used in larger health studies involving middle-aged women | Female (I): Repeatability & Validity (N = 62–66) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = 45–65 (52.6 ± 5.4)y |
Kriska, Knowler [48] | To examine the reliability and validity of the MAQ | Male (I) & Female (II): Repeatability (N = 69) Validity (N = 21) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: R = 10–59 (NR)yr.; (I) 10–59 NR; (II) 10–59 (NR)y | |
Kriska, Edelstein [49] | To compare MAQ with other PAQs among individuals with type 2 diabetes | Male: Validity (I) (N = 1043) Female: Validity (II) (N = 2191) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: NR (50.6 ± 10.7)yr.; (I) NR; (II) NR | |
Schulz, Harper [50] | To compare MAQ with direct measures of energy expenditure | Male: Validity (I) (N = 12) Female: Validity (II) (N = 9) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: NR; (I) R = NR (35.4 ± 13.8)yr.; (II) R = NR (31.3 ± 13.0)y | |
NHS II
Usual-week
| Pettee Gabriel, McClain [47] | As for MAQ | As for MAQ | As for MAQ | As for MAQ |
Phone-FITT
Usual-week
| Gill, Jones [51] | To develop the Phone-FITT and to evaluate the test–retest reliability and criterion-related (concurrent) and construct (convergent, discriminant and known-groups) validity | Male: Repeatability (I) & Validity (II) (N = 22 & 12) Female: Repeatability (III) & Validity (IV) (N = 21 & 36) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = 73–87 (79.4 ± 2.9)y; (I) 76–86 (79.4 ± 3.2)y; (II) 72–82 (76.5 ± 3.4); (III) 76–86 (79.5 ± 2.7)y; (IV) 71–89 (77.8 ± 5.1)y |
YPAS
Usual-week
| Colbert, Matthews [52] | Compared validity of a variety of physical activity measurement tools in older adults | Validity (N = 56) | Physical: Musculoskeletal conditions, lung disease, cancer and hypertension Cognitive: Not screened | Total sample: R = NR (74.7 ± 6.5)y |
Dipietro, Caspersen [53] | Preliminary repeatability data and validation results relative to selected physiologic variables | Male (I) & Female (II): Repeatability (N = 20 & 56); Validity (N = 14 & 11) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = NR (71.0 ± 6.6)y; (I) R = NR (70.9 ± 6.2)y; (II) R = NR (69.6 ± 6.0)y | |
Gennuso, Matthews [54] | Reliability and validity of physical activity surveys for assessing time spent in sedentary behavior in older adults | Validity & Repeatability (N = 58) | Physical: NR Cognitive: Not screened | Total sample: R = 66–88 (75.1 ± 6.5)y | |
Harada, Chiu [55] | Assess the known-groups and construct validity of CHAMPS, PASE and YPAS | Retirement homes (I) & Community centres (II): Validity (N = 36 & 51) | Physical: Musculoskeletal conditions, lung disease, diabetes and hypertension Cognitive: Healthy based on cognitive test | Total sample: R = 56–89 (75.0 ± 6.0); (I) R = 65–89 (79.0 ± 6.0); (II) R = 65–86 (73.0 ± 5.0) | |
Kolbe-Alexander, Lambert [56] | Validity and reliability of the YPAS and the short version of the IPAQ in older South African adults | Male (I) & Female (II): (N = 52 & 70); Sample (N) not reported between psychometric measures | Physical: NR Cognitive: Not screened | Total sample: R = 62–69 (66 ± NR)y; (I) 62–69 (67 ± NR); (II) 62–69 (65 ± NR) | |
Moore, Ellis [57] | Construct validity of four PAQs in culturally diverse older adults | African American (I) & Caucasian (II): Validity (N = 54) | Physical: Musculoskeletal conditions, neurological and cardiorespiratory Cognitive: Healthy based on cognitive test | Total sample: NR; (I) NR (67.2 ± 9.9)y; (II) NR (66.3 ± 9.8)y | |
Past-week Physical Activity Questionnaires | |||||
AAS
Past-7 days
| Brown, Trost [58] | Assessed the test-retest reliability of activity status derived from four physical activity measures | AAS (I), IPAQ (II), BRFSS (III) & NHS (IV): Repeatability (N = 356, 104, 127 & 122) | Physical: NR Cognitive: Not screened | Total sample: R = 18-75y (NR)y; (I), (II), (III) & (IV) 18-75y (NR)y |
Brown, Bauman [59] | Compared the level of agreement in prevalence estimates of the proportion of the population that is sufficiently active for health benefit derived from four measures that are in use in Australia and elsewhere around the world | AAS (I), IPAQ (II) & BRFSS (III): Validity (N = 428, 427 & 425) | Physical: NR Cognitive: Not screened | Total sample: R = 18-75y (NR)y; (I), (II) & (III) 18-75y (NR)y | |
Creamer, Bowles [60] | Determining computer-assisted approaches for surveillance of physical activity | Validity & Repeatability (N = 56) | Physical: NR Cognitive: Screened based on capability to read | Total sample: NR (43.1 ± 11.4)y | |
AAS (modified)
Past-7 days
| Fjeldsoe, Winkler [18] | Determined the test–retest reliability and criterion validity the Adapted Active Australia Survey and whether these properties varied across participants’ activity levels | Validity & Repeatability (N = 63) | Physical: NR Cognitive: Screened based on capability to read | Total sample: NR (49.5 ± 12.5)y |
CAQ-PAI
Past-7 days
| Mahabir, Baer [61] | Convergent validity of four physical activity questionnaires with DLW | Validity (N = 65) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 49.2–78.8 (59.9 ± 7.5)y |
Rauh, Hovell [62] | Reliability and convergent validity of several PAQs | Validity (N = 45) | Physical: NR Cognitive: Not screened | Total sample: 18–55 (33.0 ± 10.6)y | |
Washburn, Smith [63] | Reliability of the CAQ-PAI | Combined gender (I), Male (II) & Female (III): Repeatability (N = 633, 261 & 372) | Physical: No chronic disease conditions Cognitive: Not screened | (I) Total sample: 25–65: (39.5 ± 10.8)y; (II) NR (38.2 ± 10.6)y; (III) NR (40.5 ± 10.8) | |
Checklist Questionnaire
Past-7 days
| Masse, Fulton [64] | Compared the validity of two physical activity questionnaire formats | Validity (N = 260) | Physical: NR Cognitive: Not screened | Total sample: R = 40–70 (49.2 ± 7.0)y |
Global Questionnaire
Past-7 days
| Masse, Fulton [64] | As per Checklist Questionnaire | As per Checklist Questionnaire | As per Checklist Questionnaire | As per Checklist Questionnaire |
IPAQ-LF
Past-7 days
| Ahn, Chmiel [65] | Validity of IPAQ-SF (telephone) with accelerometer amongst adults with systemic lumpus erythematosus | Validity (N = 118) | Physical: Systemic Lupus Erythematosus Cognitive: Not screened | Total sample: NR (45.4 ± 10.9)y |
Garriguet, Tremblay [66] | Validity of IPAQ-LF (self-administered) and the new Physical Activity for Adults Questionnaire (PAAQ) with accelerometers | IPAQ-LF (I) & PAAQ (II): Validity (N = 94 & 108) | Physical: NR Cognitive: Healthy based on cognitive interview | Total sample: 18–79 (NR); (I) NR (47 ± NR)y; (II) NR (47 ± NR)y | |
IPAQ-SF
Past-7 days
| Ainsworth, Macera [67] | Compared the physical activity prevalence estimates obtained from BRFSS and IPAQ-SF (interview) | Validity (N = 9945) | Physical: Non-institutionalised Cognitive: Non-institutionalised | Total sample: R = 18–55+ (NR) |
Brown, Trost [58] | As for AAS | As for AAS | As for AAS | As for AAS | |
Brown, Bauman [59] | As for AAS | As for AAS | As for AAS | As for AAS | |
NZPAQ-LF
Past-7 days
| Moy, Scragg [68] | Convergent validity of NZPAQ-LF with heart-rate monitoring | Male (I) & Female (II): Validity (N = 90 & 96) | Physical: NR Cognitive: Not screened | Total sample: 19–86 (48.6 ± 16.4)y; (I) NR (48.4 ± NR)y; (II) NR (48.7 ± NR)y |
NZPAQ-SF
Past-7 days
| Moy, Scragg [68] | As per NZPAQ-LF | As per NZPAQ-LF | As per NZPAQ-LF | As per NZPAQ-LF |
PAAQ
Past-7 days
| Garriguet, Tremblay [66] | As for IPAQ-LF | As for IPAQ-LF | As for IPAQ-LF | As for IPAQ-LF |
PASE
Past-7 days
| Colbert, Matthews [52] | As for YPAS | As for YPAS | As for YPAS | As for YPAS |
Dinger, Oman [69] | Convergent validity and reliability of PASE with accelerometers with elderly individuals | Validity & Repeatability (N = 56) | Physical: NR Cognitive: Not screened | Total sample: NR (75.7 ± 7.9)y | |
Johansen, Painter [70] | Convergent validity of three physical activity questionnaires with accelerometers in patients with end-stage renal disease | Validity (N = 39) | Physical: Patients undergoing haemodialysis Cognitive: Not screened | Total sample: NR (52 ± 16)y | |
Moore, Ellis [57] | As for YPAS | As for YPAS | As for YPAS | As for YPAS | |
Washburn, Smith [71] | Convergent validity and reliability of PASE with accelerometers | Validity & Repeatability (N = 119) | Physical: Included participants without serious physical impairments Cognitive: Included participants without serious cognitive impairments, but screening method not clear | Total sample: NR (73.4 ± NR)y | |
PWMAQ
Past-7 days
| Pettee Gabriel, McClain [72] | Reliability and validity of PWMAQ in middle-aged women | Validity & Repeatability (N = 66) | Physical: NR Cognitive: Not screened | Total sample: NR (52.6 ± 5.4)y |
Pettee Gabriel, McClain [47] | As for MAQ | As for MAQ | As for MAQ | As for MAQ | |
PAR
Past-7 days
| Albanes, Conway [73] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI |
Blair, Haskell [74] | Construct validity of PAR | Male (I) & Female (II): Validity (N = 1077, 1206) | Physical: NR Cognitive: Not screened | Total sample: 16–74 (NR)y | |
Conway, Seale [75] | Convergent validity of PAR with DLW | Validity (N = 24) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 27–65 (41.2 ± 2.0)y | |
Garfield, Canavan [76] | As for PASE | As for PASE | As for PASE | As for PASE | |
Gross, Sallis [77] | Inter-rater reliability of PAR | Inter-rater reliability (N = 21) | Physical: NR Cognitive: Not screened | Total sample: 19–52 (NR)y | |
Irwin, Ainsworth [78] | Convergent validity of PAR with DLW | Validity (N = 24) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 27–65 (41.2 ± 9.6)y | |
Johansen, Painter [70] | As for PASE | As for PASE | As for PASE | As for PASE | |
Mahabir, Baer [61] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | |
Rauh, Hovell [62] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | |
Sallis, Haskell [79] | Reliability of PAR | Repeatability (N = 64) | Physical: NR Cognitive: Not screened | Total sample: 20–74 (40.1 ± 15.7)y | |
Sarkin, Johnson [33] | Construct validity of three physical activity questionnaires | Combined gender (I), Male (II) & Female (III): Validity (N = 575, 256 & 319) | Physical: NR Cognitive: Not screened | (I) Total sample: NR (24.5 ± 1.9)y; (II) NR (24.7 ± 2.0)y; (III) NR (24.4 ± 2.1)y | |
Taylor, Coffey [80] | Convergent validity of PAR with motion sensors | Validity (N = 30) | Physical: Some patients with myocardial infarction several 11–26 weeks prior to study Cognitive: Not screened | Total sample: 34–69 (52.3 ± NR) | |
Washburn, Jacobsen [81] | Convergent validity of PAR with DLW | Male (I) & Female (II): Validity (N = 17 & 29) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 17–35 (23.6 ± 4.2)y; (I) NR (23.9 ± 3.8)y; (II) NR (23.3 ± 4.6)y | |
Williams, Klesges [82] | Reliability and convergent validity of PAR in college students | Repeatability & Validity (N = 45) | Physical: NR Cognitive: Not screened, but were all enrolled at a university | Total sample: 18–52 (24.7 ± 7.73)y | |
VAPAQ
Past-7 days
| Betz, Myers [83] | Reproducibility of VAPAQ in an elderly population | Exercise group (I) & Usual care group (II): Repeatability (N = 26 & 29)y | Physical: All patients had abdominal aortic aneurysm Cognitive: Not screened | Total sample: NR (73.0 ± 7.9)y; (I) NR; (II) NR |
Psychometric properties of PAQs
Instrument | Study | Measurement properties | |||||
---|---|---|---|---|---|---|---|
Internal consistency | Reliability | Measurement error | Content validity | Structural validity | Hypothesis testingab | ||
Type: Score
| |||||||
Usual-week Physical Activity Questionnaires | |||||||
CaMos
Usual-week
| Nadalin, Bentvelsen [36] | NR | 78.1% (Excellent)c | NR | NR | NR | NR |
IPEQ
Usual-week
| Merom, Delbaere [37] | NR | NR | NR | NR | NR | Direct: 68.7% (Good) Indirect: 43.5% (Fair) |
MAQ
Usual-week
| Pettee Gabriel, McClain [38] | NR | 71.4% (Good)c | NR | NR | NR | Direct: 69.6% (Good) Indirect: 59.1% (Good) |
Kriska, Knowler [39] | NR | 62.1% (Good)c | NR | NR | NR | Direct: 43.5% (Fair) | |
Kriska, Edelstein [40] | NR | NR | NR | NR | NR | Direct: 78.3% (Excellent) | |
Schulz, Harper [41] | NR | NR | NR | NR | NR | Direct: 34.8% (Fair) | |
NHS II
Usual-week
| Pettee Gabriel, McClain [38] | NR | 71.4% (Good)c | NR | NR | NR | Direct: 69.6% (Good) Indirect: 59.1% (Good) |
Phone-FITT
Usual-week
| Gill, Jones [32] | NR | 62.1% (Good)c | NR | 28.5% (Fair) | NR | Direct: 69.6% (Good) Indirect: 68.1% (Good) |
YPAS
Usual-week
| Colbert, Matthews [42] | NR | 72.4% (Good)c | 75.9% (Excellent) | NR | NR | Direct: 82.4% (Excellent) |
Dipietro, Caspersen [43] | 21.7% (Poor) | 82.8% (Excellent)† | 65.5% (Good) | NR | NR | Direct: 56.5% (Good) | |
Gennuso, Matthews [44] | NR | 71.9% (Good)c | NR | NR | NR | Direct: 60.9% (Good) | |
Harada, Chiu [45] | NR | NR | NR | NR | NR | Direct: 68.1% (Good) Indirect: 75.5% (Excellent) | |
Kolbe-Alexander, Lambert [46] | NR | 56.3% (Good)c | 58.6% (Good) | NR | NR | Direct: 67.4% (Good) | |
Moore, Ellis [47] | NR | NR | NR | NR | NR | Indirect: 73.9% (Good) | |
Past-week Physical Activity Questionnaires | |||||||
AAS
Past-7 days
| Brown, Bauman [49] | NR | 78.1% (Excellent)c | NR | NR | NR | NR |
Brown, Trost [48] | NR | NR | NR | NR | NR | Direct: 60.9% (Good) | |
Creamer, Bowles [50] | NR | 72.4% (Good)c | NR | NR | NR | Direct: 82.6% (Excellent) | |
AAS (modified)
Past-7 days
| Fjeldsoe, Winkler [12] | NR | 72.2% (Good)c | 72.4% (Good) | NR | NR | Direct: 78.3% (Excellent) |
CAQ-PAI
Past-7 days
| Mahabir, Baer [51] | NR | NR | NR | NR | NR | Direct: 54.3% (Good) |
Rauh, Hovell [52] | NR | 65.5% (Good)c | NR | NR | NR | Direct: 60.9% (Good) Indirect: 60.9% (Good) | |
Washburn, Smith [53] | NR | 72.4% (Good)c | NR | NR | NR | Indirect: 65.2% (Good) | |
Checklist Questionnaire
Past-7 days
| Masse, Fulton [54] | NR | NR | NR | NR | NR | Direct: 69.6% (Good) |
Global Questionnaire
Past-7 days
| Masse, Fulton [54] | NR | NR | NR | NR | NR | Direct: 69.6% (Good) |
IPAQ-LF
Past-7 days
| Ahn, Chmiel [55] | NR | NR | NR | NR | NR | Direct: 78.3% (Excellent) |
Garriguet, Tremblay [56] | NR | NR | NR | NR | NR | Direct: 69.6% (Good) | |
IPAQ-SF
Past-7 days
| Ainsworth, Macera [57] | NR | NR | NR | NR | NR | Direct: 78.2% (Excellent) |
Brown, Bauman [49] | NR | 78.1% (Excellent)c | NR | NR | NR | NR | |
Brown, Trost [48] | NR | NR | NR | NR | NR | Direct: 60.9% (Good) | |
NZPAQ-LF
Past-7 days
| Moy, Scragg [58] | NR | NR | NR | NR | NR | Indirect: 82.6% (Excellent) |
NZPAQ-SF
Past-7 days
| Moy, Scragg [58] | NR | NR | NR | NR | NR | Indirect: 82.6% (Excellent) |
PAAQ
Past-7 days
| Garriguet, Tremblay [56] | NR | NR | NR | 57.1% (Good) | NR | Direct: 78.3% (Excellent) |
PASE
Past-7 days
| Colbert, Matthews [42] | NR | 72.4% (Good)c | 75.9% (Excellent) | NR | NR | Direct: 82.4% (Excellent) |
Dinger, Oman [59] | NR | 72.4% (Good)c | NR | NR | NR | Direct: 82.6% (Excellent) | |
Johansen, Painter [60] | NR | NR | NR | NR | NR | Direct: 69.6% (Good) Indirect: 43.5% (Fair) | |
Moore, Ellis [47] | NR | NR | NR | NR | NR | Indirect: 73.9% (Good) | |
Washburn, Smith [61] | 43.5% (Fair) | 82.8% (Excellent)c | NR | 71.4% (Good) | NR | Indirect: 68.8% (Good) | |
PWMAQ
Past-7 days
| Pettee Gabriel, McClain [62] | NR | 72.4% (Good)c | NR | NR | NR | Direct: 69.6% (Good) |
Pettee Gabriel, McClain [38] | NR | 71.4% (Good)c | NR | NR | NR | Direct: 69.6% (Good) Indirect: 59.1% (Good) | |
PAR
Past-7 days
| Albanes, Conway [63] | NR | NR | NR | NR | NR | Direct: 30.4% (Fair) |
Blair, Haskell [64] | NR | NR | NR | NR | NR | Direct: 78.3% (Excellent) Indirect: 78.3% (Excellent) | |
Conway, Seale [65] | NR | NR | NR | NR | NR | Direct: 69.6% (Good) | |
Garfield, Canavan [66] | NR | NR | NR | NR | NR | Direct: 56.5% (Good) | |
Gross, Sallis [67] | NR | 58.6% (Good)d | NR | NR | NR | NR | |
Irwin, Ainsworth [68] | NR | NR | NR | NR | NR | Direct: 52.2% (Good) Indirect: 52.2% (Good) | |
Johansen, Painter [60] | NR | NR | NR | NR | NR | Direct: 65.2% (Good) Indirect) 56.5% (Good) | |
Mahabir, Baer [51] | NR | NR | NR | NR | NR | Direct: 65.2% (Good) | |
Rauh, Hovell [52] | NR | 65.5% (Good)c | NR | NR | NR | Direct: 60.9% (Good) Indirect: 60.9% (Good) | |
Sallis, Haskell [69] | 36.4% (Fair) | 79.3% (Excellent)c | NR | NR | NR | Indirect: 73.9% (Good) | |
Sarkin, Johnson [70] | NR | NR | NR | NR | NR | Divergent: 34.8% (Fair) | |
Taylor, Coffey [71] | NR | NR | NR | NR | NR | Direct: 56.5% (Good) Indirect: 56.5% (Good) | |
Washburn, Jacobsen [72] | NR | NR | NR | NR | NR | Direct: 65.2% (Good) | |
Williams, Klesges [73] | NR | 55.2% (Good)c | NR | NR | NR | Direct: 60.9% (Good) | |
VAPAQ
Past-7 days
| Betz, Myers [74] | NR | 58.6% (Good)c | 62.1% (Good) | NR | NR | NR |
Instrument | r-values | Sample (n) |
---|---|---|
Reliability testing | ||
CaMos Usual-week | NR | NR |
IPEQ-WA Usual-week | NR | NR |
MAQ Usual-week | 0.91 | 46 |
NHS II Usual 7-days | NR | NR |
Phone-FITT Usual-week | NR | NR |
YPAS Usual 7-days | 0.56 | 198 |
AAS Past 7-days | NR | NR |
AAS (modified) Past 7-days | 0.65 | 63 |
CAQ-PAI Past 7-days | 0.53 | 633 |
Checklist Questionnaire Past 7-days | NR | NR |
Global Questionnaire Past 7-days | NR | NR |
IPAQ-LF Past 7-days | NR | NR |
IPAQ-SF Past 7-days | NR | NR |
NZPAQ-LF Past 7-days | NR | NR |
NZPAQ-SF Past 7-days | NR | NR |
PAAQ Past 7-days | NR | NR |
PASE Past 7-days | 0.68 | 144 |
PWMAQ Past 7-days | NR | NR |
PAR Past 7-days | 0.65 | 118 |
VAPAQ Past 7-days | 0.93 | 55 |
Average for Usual-week PAQs | 0.63 | 244 |
Average for Past-week PAQs | 0.56 | 950 |
Convergent validity testing | ||
CaMos | ||
Usual-week | ||
Direct & Indirect | NR | NR |
Direct | ||
Indirect | ||
IPEQ-WA | ||
Usual-week | ||
Direct & Indirect | 0.28 | 553 |
Direct | 0.22 | 177 |
Indirect | 0.31 | 376 |
MAQ | ||
Usual-week | ||
Direct & Indirect | 0.47 | 118 |
Direct | 0.57 | 118 |
Indirect | 0.23 | 66 |
NHS II | ||
Usual 7-days | ||
Direct & Indirect | 0.27 | 66 |
Direct | 0.43 | 66 |
Indirect | 0.22 | 66 |
Phone-FITT | ||
Usual-week | ||
Direct & Indirect | 0.36 | 84 |
Direct | 0.44 | 48 |
Indirect | 0.25 | 36 |
YPAS | ||
Usual 7-days | ||
Direct & Indirect | 0.36 | 2099 |
Direct | 0.43 | 824 |
Indirect | 0.34 | 1182 |
AAS | ||
Past 7-days | ||
Direct & Indirect | NR | NR |
Direct | NR | NR |
Indirect | NR | NR |
AAS (modified) | ||
Past 7-days | ||
Direct & Indirect | 0.57 | 63 |
Direct | 0.57 | 63 |
Indirect | NR | NR |
CAQ-PAI | ||
Past 7-days | ||
Direct & Indirect | 0.15 | 3731 |
Direct | 0.46 | 65 |
Indirect | 0.14 | 3666 |
Checklist Questionnaire | ||
Past 7-days | ||
Direct & Indirect | 0.46 | 2231 |
Direct | 0.46 | 2231 |
Indirect | NR | NR |
Gobal Questionnaire | ||
Past 7-days | ||
Direct & Indirect | 0.35 | 2231 |
Direct | 0.35 | 2231 |
Indirect | NR | NR |
IPAQ-LF | ||
Past 7-days | ||
Direct & Indirect | 0.23 | 436 |
Direct | 0.23 | 436 |
Indirect | NR | NR |
IPAQ-SF | ||
Past 7-days | ||
Direct & Indirect | 0.34 | 25.2 |
Direct | 0.34 | 25.2 |
Indirect | NR | NR |
NZPAQ-LF | ||
Past 7-days | ||
Direct & Indirect | NA | NA |
Direct | 0.25 | 186 |
Indirect | NR | NR |
NZPAQ-SF | ||
Past 7-days | ||
Direct & Indirect | NR | NR |
Direct | 0.25 | 186 |
Indirect | NR | NR |
PAAQ | ||
Past 7-days | ||
Direct & Indirect | 0.41 | 318 |
Direct | 0.41 | 318 |
Indirect | NR | NR |
PASE | ||
Past 7-days | ||
Direct & Indirect | 0.31 | 355 |
Direct | 0.44 | 95 |
Indirect | 0.27 | 260 |
PWMAQ | ||
Past 7-days | ||
Direct & Indirect | 0.51 | 64 |
Direct | 0.51 | 64 |
Indirect | NR | NR |
PAR | ||
Past 7-days | ||
Direct & Indirect | 0.25 | 3539 |
Direct | 0.39 | 874 |
Indirect | 0.21 | 2547 |
VAPAQ | ||
Past 7-days | ||
Direct & Indirect | NR | NR |
Direct | NR | NR |
Indirect | NR | NR |
Average for Usual-week PAQs | Direct & Indirect (r = 0.30) | Direct & Indirect (n = 4730) |
Direct (r = 0.33) | Direct (n = 2019) | |
Indirect (r = 0.28) | Indirect (n = 2711) | |
Average for Past-week PAQs | Direct & Indirect (r = 0.28) | Direct & Indirect (n = 14,147) |
Direct (r = 0.40) | Direct (n = 6182) | |
Indirect (r = 0.19) | Indirect (n = 7965) | |
Past-week and Usual-week PAQs | Direct (r = 0.39) | Direct (n = 8201) |
Indirect (r = 0.21) | Indirect (n = 10,676) |
Assessment | Reference | Measurement properties of questionnaires | |||||
---|---|---|---|---|---|---|---|
Reliability | Construct validity | ||||||
Internal Consistency | Reliability | Measurement error | Content validity | Structural validity | Hypothesis testingab | ||
Usual-week Physical Activity Questionnaires | |||||||
CaMos Usual-week | Nadalin, Bentvelsen [36] | NR | – | NR | NR | NR | NR |
IPEQ Usual-week | Merom, Delbaere [37] | NR | NR | NR | NR | NR | - (Direct) - (Indirect) |
MAQ Usual-week | Pettee Gabriel, McClain [38] | NR | – | NR | NR | NR | - (Direct) - (Indirect) |
Kriska, Knowler [39] | NR | + | NR | NR | NR | ± (Direct) | |
Kriska, Edelstein [40] | NR | NR | NR | NR | NR | - (Direct) | |
Schulz, Harper [41] | NR | NR | NR | NR | NR | + (Direct) | |
NHS II Usual-week | Pettee Gabriel, McClain [38] | NR | – | NR | NR | NR | ± (Direct) - (Indirect) |
Phone-FITT Usual-week | Gill, Jones [32] | NR | + | NR | – | NR | - (Direct) - (Indirect) |
YPAS Usual-week | Colbert, Matthews [42] | NR | + | ? | NR | NR | - (Direct) |
Dipietro, Caspersen [43] | NE | – | ? | NR | NR | - (Direct) - (Indirect) | |
Gennuso, Matthews [44] | NR | – | NR | NR | NR | ? (Direct) | |
Harada, Chiu [45] | NR | NR | NR | NR | NR | + (Direct) - (Indirect) | |
Kolbe-Alexander, Lambert [46] | NR | – | ? | NR | NR | - (Direct) | |
Moore, Ellis [47] | NR | NR | NR | NR | NR | - (Indirect) | |
Past-week Physical Activity Questionnaires | |||||||
Active Australia Survey Past week | Brown, Bauman [49] | NR | – | NR | NR | NR | NR |
Brown, Trost [48] | NR | NR | NR | NR | NR | - (Direct) | |
Creamer, Bowles [50] | NR | + | NR | NR | NR | - (Direct) | |
Active Australia Survey (modified) Past-week | Fjeldsoe, Winkler [12] | NR | – | ? | NR | NR | + (Direct) |
CAQ-PAI Past-week | Mahabir, Baer [51] | NR | NR | NR | NR | NR | - (Direct) |
Rauh, Hovell [52] | NR | – | NR | NR | NR | - (Direct) - (Indirect) | |
Washburn, Smith [53] | NR | – | NR | NR | NR | - (Indirect) + (Discriminant) | |
Checklist Questionnaire Past-week | Masse, Fulton [54] | NR | NR | NR | NR | NR | ± (Direct) |
Global Questionnaire Past-week | Masse, Fulton [54] | NR | NR | NR | NR | NR | - (Direct) |
IPAQ-LF (self-administered) Past-week | Ahn, Chmiel [55] | NR | NR | NR | NR | NR | - (Direct) |
Garriguet, Tremblay [56] | NR | NR | NR | NR | NR | - (Direct) | |
IPAQ-SF(interview) Past-week | Ainsworth, Macera [57] | NR | NR | NR | NR | NR | - (Direct) |
Brown, Bauman [49] | NR | – | NR | NR | NR | NR | |
Brown, Trost [48] | NR | NR | NR | NR | NR | - (Direct) | |
NZPAQ-LF Past-week | Moy, Scragg [58] | NR | NR | NR | NR | NR | - (Direct) |
NZPAQ-SF Past-week | Moy, Scragg [58] | NR | NR | NR | NR | NR | - (Direct) |
PAAQ Past-week | Garriguet, Tremblay [56] | NR | NR | NR | – | NR | - (Direct) |
PASE Past-week | Colbert, Matthews [42] | NR | – | ? | NR | NR | - (Direct) |
Dinger, Oman [59] | NR | + | NR | NR | NR | - (Direct) | |
Johansen, Painter [60] | NR | NR | NR | NR | NR | + (Direct) - (Indirect) | |
Moore, Ellis [47] | NR | NR | NR | NR | NR | - (Indirect) | |
Washburn, Smith [61] | – | – | NR | + | NR | - (Indirect) | |
PWMAQ Past-week | Pettee Gabriel, McClain [62] | NR | + | NR | NR | NR | + (Direct) |
Pettee Gabriel, McClain [38] | NR | + | NR | NR | NR | - (Direct) - (Indirect) | |
PAR Past-week | Albanes, Conway [63] | NR | NR | NR | NR | NR | - (Direct) |
Blair, Haskell [64] | NR | NR | NR | NR | NR | - (Direct) - (Indirect) | |
Conway, Seale [65] | NR | NR | NR | NR | NR | - (Direct) | |
Garfield, Canavan [66] | NR | NR | NR | NR | NR | + (Direct) | |
Gross, Sallis [67] | NR | + | NR | NR | NR | NR | |
Irwin, Ainsworth [68] | NR | NR | NR | NR | NR | - (Indirect) | |
Johansen, Painter [60] | NR | NR | NR | NR | NR | + (Direct) - (Indirect) | |
Mahabir, Baer [51] | NR | NR | NR | NR | NR | - (Direct) | |
Rauh, Hovell [52] | NR | – | NR | NR | NR | - (Direct) - (Indirect) | |
Sallis, Haskell [69] | ? | – | NR | NR | NR | - (Indirect) | |
Sarkin, Johnson [70] | NR | NR | NR | NR | NR | ? (Indirect) | |
Taylor, Coffey [71] | NR | NR | NR | NR | NR | + (Direct) | |
Washburn, Jacobsen [72] | NR | NR | NR | NR | NR | - (Direct) - (Indirect) | |
Williams, Klesges [73] | NR | + | NR | NR | NR | ± (Direct) | |
VAPAQ Past-week | Betz, Myers [74] | NR | + | ? | NR | NR | NR |
Assessment | Internal Consistency | Reliability | Measurement error | Content validity | Structural validity | Hypothesis testing |
---|---|---|---|---|---|---|
CaMos Usual-week | NR | Strong Negative | NR | NR | NR | NR |
IPEQ Usual-week | NR | NR | NR | NR | NR | Moderate Negative |
MAQ Usual-week | NR | Conflicting | NR | NE | NR | Conflicting |
NHS II Usual-week | NR | Moderate Negative | NR | NR | NR | Conflicting |
Phone-FITT Usual-week | NR | Moderate Positive | NR | Limited Negative | NR | Moderate Negative |
YPAS Usual-week | Not Evaluated | Conflicting | Indeterminate | NR | NR | Conflicting |
AAS Past-7 days | NR | Conflicting | NR | NR | NR | Strong Negative |
AAS (modified) Past-7 days | NR | Strong Negative | Indeterminate | NR | NR | Strong Positive |
CAQ-PAI Past-7 days | NR | Strong Negative | NR | NR | NR | Conflicting |
Checklist Questionnaire Past-7 days | NR | NR | NR | NR | NR | Conflicting |
Global Questionnaire Past-7 days | NR | NR | NR | NR | NR | Moderate Negative |
IPAQ-LF (self-administered) Past-7 days | NR | NR | NR | NR | NR | Strong Negative |
IPAQ-SF (interview) Past-7 days | NR | Strong Negative | NR | NR | NR | Strong Negative |
NZPAQ-LF Past-7 days | NR | NR | NR | NR | NR | Strong Negative |
NZPAQ-SF Past-7 days | NR | NR | NR | NR | NR | Strong Negative |
PAAQ Past-7 days | NR | NR | NR | Moderate Negative | NR | Strong Negative |
PASE Past-7 days | Limited Negative | Conflicting | Indeterminate | Moderate Positive | NR | Conflicting |
PWMAQ Past-7 days | NR | Strong Positive | NR | NR | NR | Conflicting |
PAR Past-7 days | Indeterminate | Conflicting | NR | NR | NR | Conflicting |
VAPAQ Past-7 days | NR | Moderate Positive | Indeterminate | NR | NR | NR |